Daphna Mokady

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Endogena Therapeutics, Inc.. Active years: 2020-2025.

USPTO Granted Patents = 3 (Patent Applications = 1)

% Patents Active = 66.7

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 4(Granted Patents)

Company Filing History:

3 out of 6

Endogena Therapeutics, Inc.

patents

Years Active: 2020-2025

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12195452 - N-(4-(oxazol-5-yl)phenyl) chromane-3-carboxamide derivatives and related compounds as stimulators of the production of retinal precursor cells for the treatment of neuroretinal diseases (2025-01-14),

2. 10807973 - Compounds for use as therapeutically active substances in the treatment of retinal diseases (2020-10-20),

3. 10752593 - Compounds for use as therapeutically active substances in the treatment of retinal diseases (2020-08-25),

This text is generated by artificial intelligence and may not be accurate.